Article

Efficacy, Safety, and Tolerability of Halobetasol Propionate 0.01%–Tazarotene 0.045% Lotion for Moderate to Severe Plaque Psoriasis in the Hispanic Population: Post Hoc Analysis
- Author:
- Andrew F. Alexis, MD, MPH
- Paul S. Yamauchi, MD, PhD
- Seemal R. Desai, MD
- Nelly Khaselev, MSc
- Tina Lin, PharmD
Although psoriasis is a common inflammatory disease, data in the Hispanic population are sparse and disease may be more severe. A recent clinical...
Article

Safety and Efficacy of Halobetasol Propionate Lotion 0.01% in the Treatment of Moderate to Severe Plaque Psoriasis: A Pooled Analysis of 2 Phase 3 Studies
- Author:
- Jeffrey L. Sugarman, MD, PhD
- Jonathan S. Weiss, MD
- Emil A. Tanghetti, MD
- Jennifer Soung, MD
- Paul S. Yamauchi, MD
- Tina Lin, PharmD
- Susan Harris, MS
- Gina Martin, MOT
- Radhakrishnan Pillai, PhD
Potent topical corticosteroids are the mainstay of psoriasis treatment, but safety concerns have limited use to 2 to 4 weeks. This study...
Article

Efinaconazole Solution 10% for Treatment of Toenail Onychomycosis in Latino Patients
- Author:
- Fran E. Cook-Bolden, MD
- Tina Lin, PharmD
Onychomycosis is a common progressive fungal infection of the nail bed, matrix, or plate leading to destruction and deformity of the toenails and...